Dr Reddys announces cessation of subsidiary in Louisiana
24 - Mar - 2025 12:00 | 7 days ago
Dr. Reddy's Laboratories Inc., USA, a wholly owned subsidiary of the Company, has successfully completed the sale of all issued and outstanding membership interests in its wholly owned subsidiary viz; Dr. Reddy's Laboratories Louisiana LLC, including the manufacturing facility located in Shreveport, Louisiana, USA, on March 21, 2025.
Consequently, Dr. Reddy's Laboratories Louisiana LLC has ceased to be a wholly owned subsidiary of Dr. Reddy's Laboratories Inc. and a step-down wholly owned subsidiary of Dr. Reddy's Laboratories effective from 21 March 2025.
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
13 - Mar - 2025 12:00 | 18 days ago
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the United States.
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
13 - Mar - 2025 12:00 | 18 days ago
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the United States.
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
Dr Reddys announces cessation of subsidiary in Louisiana
24 - Mar - 2025 12:00 | 7 days ago
Dr. Reddy's Laboratories Inc., USA, a wholly owned subsidiary of the Company, has successfully completed the sale of all issued and outstanding membership interests in its wholly owned subsidiary viz; Dr. Reddy's Laboratories Louisiana LLC, including the manufacturing facility located in Shreveport, Louisiana, USA, on March 21, 2025.
Consequently, Dr. Reddy's Laboratories Louisiana LLC has ceased to be a wholly owned subsidiary of Dr. Reddy's Laboratories Inc. and a step-down wholly owned subsidiary of Dr. Reddy's Laboratories effective from 21 March 2025.
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
13 - Mar - 2025 12:00 | 18 days ago
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the United States.
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
Dr Reddys announces cessation of subsidiary in Louisiana
24 - Mar - 2025 12:00 | 7 days ago
Dr. Reddy's Laboratories Inc., USA, a wholly owned subsidiary of the Company, has successfully completed the sale of all issued and outstanding membership interests in its wholly owned subsidiary viz; Dr. Reddy's Laboratories Louisiana LLC, including the manufacturing facility located in Shreveport, Louisiana, USA, on March 21, 2025.
Consequently, Dr. Reddy's Laboratories Louisiana LLC has ceased to be a wholly owned subsidiary of Dr. Reddy's Laboratories Inc. and a step-down wholly owned subsidiary of Dr. Reddy's Laboratories effective from 21 March 2025.
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
13 - Mar - 2025 12:00 | 18 days ago
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the United States.
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
13 - Mar - 2025 12:00 | 18 days ago
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the United States.
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
